Drug Interaction Types - Global
DI.10 QT Prolongation Risk
Drug Interaction Type classification code DI.10 covers "QT Prolongation Risk" at level 2 of the Drug Interaction Type hierarchy.
Level 2
Is your business really a DI.10?Classify itWhere DI.10 sits in the Drug Interaction Type hierarchy
- >DI Drug Interaction Types
- >>DI.10 QT Prolongation Risk
- >>DI.10 QT Prolongation Risk
Other Drug Interaction Type codes under DI.10 QT Prolongation Risk
- DI.01Pharmacokinetic Interaction
- DI.02Pharmacodynamic Interaction
- DI.03Drug-Drug Interaction
- DI.04Drug-Food Interaction
- DI.05Drug-Herb Interaction
- DI.06Drug-Lab Test Interaction
- DI.07CYP450 Enzyme Inhibition
- DI.08CYP450 Enzyme Induction
- DI.09P-glycoprotein Interaction
- DI.11Serotonin Syndrome Risk
- DI.12Renal Clearance Interaction
- DI.13Protein Binding Displacement
- DI.14Additive Toxicity
Frequently asked questions
- What is Drug Interaction Type DI.10?
- Drug Interaction Type DI.10 is "QT Prolongation Risk". Drug Interaction Type code DI.10 covers "QT Prolongation Risk" at level 2 of the Drug Interaction Type hierarchy.
- What is the parent category of DI.10?
- DI.10 QT Prolongation Risk sits under DI.10 QT Prolongation Risk in the Drug Interaction Type hierarchy.
Classify my business
Describe your business in plain English and get matching codes across Drug Interaction Type and other major systems.
Interactive browser
Open DI.10 in the full interactive explorer with tree view, search, and drill-downs.